| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |